Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JNYN | ISIN: US05338G1067 | Ticker-Symbol: N/A
1-Jahres-Chart  (nicht börsennotiert)
AVALARA INC Chart 1 Jahr
PR Newswire
474 Leser
Artikel bewerten:
(2)

Avalara, Inc.: Avalara Survey Finds Brexit is Costly, Complex, and Driving Down Profitability for UK Businesses

Finanznachrichten News
  • Since the Brexit decision in 2020, enterprise businesses report a loss of £143,870, according to new research commissioned by Avalara, a market leader in tax compliance software
  • 26% of businesses report supply chain challenges when trading with the European Union (EU)
  • Most businesses in the United Kingdom (81%) face increased cross-border complexity compared to 2020, and 68% are actively expanding into non-EU markets

BRIGHTON, United Kingdom, Jan. 31, 2024 /PRNewswire/ -- Avalara, Inc., a leading provider of tax compliance automation software for businesses of all sizes, has today published new analysis exploring the impact of Brexit on businesses based in the United Kingdom (UK). The findings reveal that leaving the European Union (EU) generated additional costs for UK businesses, costing £96,281 on average since 2020. The survey also revealed that 73% of UK businesses report being less profitable in the wake of the decision.

Avalara

"Businesses in the UK are feeling the negative financial impact of Brexit on their bottom line. Thousands of businesses are reeling from the customs and tax obligations imposed on trade across Europe," commented Alex Baulf, Vice President of Global Indirect Tax and E-Invoicing at Avalara. "At a time when the UK economy needs to repair itself, encouraging business growth and expansion is key. Unlocking cross-border trade should be central to this."

Businesses report disruptions post-Brexit
One of the main drivers behind Britain's decision to leave the EU was its trading relationship with the customs union. However, 78% of UK business leaders claim that the UK did not experience a trade boom. Most UK businesses (81%) believe they face more cross-border complexity today than they did before Brexit. Further, 26% of UK businesses have reported disrupted supply chains post-Brexit.

Three-quarters (75%) of UK businesses saw their sales into the EU fall or become more complicated, driven by the increased complexity when trading with Europe. As a response, over two-thirds (68%) of businesses have explored trading into non-EU markets following Britain's exit. Businesses are actively expanding and investing into the US (45%), Canada (41%), New Zealand (27%) and China (26%). Overwhelmingly, 82% of British businesses would support the UK Government's efforts in improving trade across Europe.

Business have turned to technology to navigate the post-Brexit landscape
British businesses continue to feel the effects of Brexit. Brexit has forced almost half (43%) of UK businesses to invest in technology to improve their operations. Nearly a third (29%) of Scottish businesses have had to reduce exports to the EU, and companies in the South East of England have had to pivot their operations (26%) in order to succeed. In Wales, 29% have had to refocus away from customer experience to combat Brexit's fallout.

With only 18% of British businesses reporting no impact from Brexit, it is no surprise that three-quarters (74%) of business leaders believe Brexit created more stress for businesses. More businesses reported stress across the arts and culture (94%), healthcare (90%), and HR and education (both 88%) industries.

Avalara provides an end-to-end platform to address cross-border tax compliance - from tariff code classifications to customs duty and import tax calculations and more. To learn more about how Avalara automates cross-border tax compliance requirements for businesses, visit avalara.com.

About Avalara
Avalara makes tax compliance faster, easier, more accurate, and more reliable for 41,000+ business and government customers in over 75 countries. Tax compliance automation software solutions from Avalara leverage 1,200+ signed partner integrations across leading ecommerce, ERP, and other billing systems to power tax calculations, document management, tax return filing, and tax content access. Visit avalara.com to improve your compliance journey.

Methodology
The research was conducted by Censuswide, with 1001 senior business decision-makers (aged 18+) in the UK within businesses / retailers that trade and / or sell goods cross-border (priority) and at the following companies: E-commerce businesses, Manufacturing businesses and Digital services businesses. The research ran between 15.01.2024 - 22.01.2024. Censuswide abide by and employ members of the Market Research Society which is based on the ESOMAR principles. Censuswide are also members of the British Polling Council.

Logo - https://mma.prnewswire.com/media/2148367/Avalara_Logo_Tag_RGB_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/avalara-survey-finds-brexit-is-costly-complex-and-driving-down-profitability-for-uk-businesses-302047516.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.